Medpace is a clinical contract research organization that provides outsourced drug and device development services, managing clinical trials for biopharmaceutical and medical-device companies.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Paul Tudor Jones / Tudor | 61 | New buy | 846 | $528,056 | 0.0% |
| Steve Cohen / Point72 | 75 | New buy | 15,812 | $9,869,534 | 0.0% |
| Bridgewater | 55 | Added +269% | 57,506 | $35,894,095 | 0.2% |
| Ancora | 42 | Holds (flat) | 42 | $26,216 | 0.0% |
| François Rochon / Giverny | 69 | Trimmed -52% | 244,746 | $152,765,558 | 5.2% |
| Terry Smith / Fundsmith | 66 | Trimmed -50% | 25,940 | $16,191,229 | 0.1% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-05-15 | David J. Taylor OH02 | BUY | $1,001 - $15,000 | PTR |
| 2026-05-15 | David J. Taylor OH02 | BUY | $1,001 - $15,000 | PTR |
| 2026-02-26 | David J. Taylor OH02 | BUY | $1,001 - $15,000 | PTR |
| 2026-01-29 | David J. Taylor OH02 | BUY | $1,001 - $15,000 | PTR |
| 2026-01-16 | David J. Taylor OH02 | SELL | $1,001 - $15,000 | PTR |
| 2026-01-15 | Gilbert Cisneros CA31 | SELL | $15,001 - $50,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.